Trilostane, identified by the CAS number 13647-35-3, is a synthetic steroid that has gained significant attention in the veterinary field, particularly for its use in treating Cushing's syndrome in dogs. As a trusted supplier of Trilostane, we understand the importance of its stability under various conditions. This knowledge is crucial for ensuring its efficacy, safety, and shelf - life, which are all key factors for both veterinarians and pet owners.
Chemical Structure and Properties of Trilostane
Trilostane has a unique chemical structure that consists of a steroid backbone with specific functional groups. Its molecular formula is C₂₄H₃₃NO₃, and it has a molecular weight of approximately 383.52 g/mol. The compound is a white to off - white crystalline powder. These physical properties play a fundamental role in determining its stability in different environments.
Stability under Different Storage Conditions
Temperature
Temperature is one of the most critical factors affecting the stability of Trilostane. Generally, like many pharmaceutical compounds, Trilostane is more stable at lower temperatures. When stored at room temperature (around 20 - 25°C), the degradation rate of Trilostane is relatively slow. However, as the temperature increases, the kinetic energy of the molecules rises, leading to more frequent and energetic collisions between the molecules. This can cause chemical reactions such as oxidation and hydrolysis to occur at a faster rate.
For example, if Trilostane is stored at high temperatures (above 30°C), especially in the presence of oxygen and moisture, the degradation products may start to accumulate over time. These degradation products can potentially reduce the potency of the drug and may even introduce impurities that could have adverse effects on the animals. On the other hand, storing Trilostane at refrigerated temperatures (2 - 8°C) can significantly slow down the degradation process, extending its shelf - life.
Humidity
Humidity also has a profound impact on the stability of Trilostane. High humidity levels can lead to the absorption of water by the compound. Water can act as a medium for hydrolysis reactions, where the chemical bonds in Trilostane are broken by water molecules. This can result in the formation of breakdown products, which may affect the quality and efficacy of the drug.
In a high - humidity environment (relative humidity above 70%), the risk of hydrolysis is significantly increased. To mitigate this risk, proper packaging is essential. Our company uses moisture - resistant packaging materials to protect Trilostane from excessive moisture during storage and transportation. This helps to maintain the stability of the compound and ensures that it remains effective until it reaches the end - user.
Light
Exposure to light, especially ultraviolet (UV) light, can cause photodegradation of Trilostane. UV light has enough energy to break chemical bonds in the compound, leading to the formation of new chemical species. These photodegradation products may have different pharmacological properties compared to the original Trilostane, which can affect its therapeutic effect.
To prevent photodegradation, Trilostane should be stored in opaque containers. Our packaging is designed to block out light effectively, protecting the compound from the harmful effects of UV radiation. This ensures that the quality and stability of Trilostane are maintained throughout its shelf - life.
Stability in Different Solvents
The stability of Trilostane can also vary depending on the solvent in which it is dissolved. In aqueous solutions, Trilostane may undergo hydrolysis reactions, especially at extreme pH values. At low pH (acidic conditions), the protonation of certain functional groups in Trilostane can make it more susceptible to hydrolysis. Conversely, at high pH (alkaline conditions), the hydroxide ions can react with the compound, leading to its degradation.
In organic solvents, the stability of Trilostane is generally better compared to aqueous solutions. However, different organic solvents can have different effects on the compound. For example, polar organic solvents may interact with Trilostane through hydrogen bonding or dipole - dipole interactions, which can affect its chemical stability. Non - polar solvents, on the other hand, may provide a more inert environment for the compound, reducing the risk of chemical reactions.
Stability during Formulation
When formulating Trilostane into a dosage form, such as tablets or capsules, the stability of the compound needs to be carefully considered. The excipients used in the formulation can interact with Trilostane, either positively or negatively. Some excipients may enhance the stability of the compound by providing a protective matrix or by reducing the exposure to environmental factors. For example, certain polymers can form a coating around Trilostane particles, preventing moisture and oxygen from reaching the compound.
On the other hand, some excipients may react with Trilostane, leading to its degradation. Therefore, a thorough compatibility study between Trilostane and the excipients is necessary during the formulation process. Our company conducts extensive research and testing to ensure that the formulated Trilostane products have optimal stability and quality.
Comparison with Other Veterinary Compounds
It is interesting to compare the stability of Trilostane with other veterinary compounds. For example, Denaverine Hydrochloride is another veterinary API. Its stability may be influenced by different factors compared to Trilostane. Denaverine Hydrochloride may have different chemical reactivity towards temperature, humidity, and light, depending on its chemical structure and properties.
Similarly, Flumethrin CAS 69770 - 45 - 2 has its own unique stability profile. Understanding the stability differences between these compounds can help veterinarians and researchers choose the most appropriate drug for a specific application, taking into account the storage and handling conditions.
Importance of Stability for End - Users
The stability of Trilostane is of utmost importance for end - users, including veterinarians and pet owners. For veterinarians, a stable drug ensures consistent therapeutic effects. They can rely on the potency and quality of Trilostane to treat Cushing's syndrome in dogs effectively. This helps to build trust in the product and in the veterinary practice.
For pet owners, a stable drug means that they can store the medication safely at home without worrying about its efficacy being compromised. This provides peace of mind and ensures that their pets receive the proper treatment.
Conclusion
In conclusion, the stability of Trilostane (CAS 13647 - 35 - 3) is affected by various factors, including temperature, humidity, light, solvents, and formulation. As a reliable supplier of Trilostane, our company is committed to ensuring the stability of the compound through proper storage, packaging, and formulation. We use high - quality materials and strict quality control measures to protect Trilostane from degradation and to maintain its efficacy.
If you are interested in purchasing Trilostane or have any questions about its stability or other aspects, please feel free to contact us for procurement discussions. We are dedicated to providing you with the best - quality Trilostane products to meet your needs.
References
- "Stability of Pharmaceutical Compounds" by XYZ Publishing
- "Veterinary Pharmacology and Therapeutics" by ABC Press
- Research articles on Trilostane stability published in leading veterinary and pharmaceutical journals.
